Navigation Links
Elixir Bio-Tech Inc. Elected One of Top 50 Emerging Companies by 100 Venture Capital Funds & Angel Investors

LAS CRUCES, N.M., Feb. 2, 2011 /PRNewswire/ -- Elixir Bio-Tech Inc. (EBT), a New Mexico Algae Biotech company, has been named one of the top fifty winners of the FundingPost's 7th annual "Pitching Across America™" competition.

EBT is launching its Algae Biomass Feedstock project in Luna County, NM to demonstrate accelerated approaches in producing multi-purpose feedstock with ground-breaking Proprietary and Patent Pending Technology for Open and Closed Algae Biomass Systems. EBT's experienced Algae engineering, production, and marketing team, is establishing strategic partners.

FundingPost (, a company that has been Introducing entrepreneurs to investors for almost 5 years, established the "Pitching Across America, (PAA)" the largest Venture Capital competition ever organized, in which Venture Funds and Investors served as judges voting on 300 business summaries from emerging companies nationwide. PAA was sponsored by WolfBlock ( and PRNewswire (  

Emerging companies were evaluated on a scale of 1 to 10. Judging criteria consisted of key points: the professionalism of the written summary, current stage of development, competitive advantage, need in the marketplace, feasibility for success, and whether the company is "VentureWorthy(TM)."

"We're very pleased to have been chosen for recognition from such an impressive list of companies throughout the U.S.," said Richard Warren, CEO of Elixir Bio-Tech Inc., a "Grass Roots" company: "FundingPost has given us an opportunity to reach an excellent selection of visionary investors. While our customer base continues to grow, in the Algae Nutraceutical markets, the right funding partner(s) can accelerate the establishment of the company's production facility. Our company also plans to benefit from biofuel collaborations with NMSU, Santa Fe College and Sapphire through subcontracting, R&D work study and local employment."

FundingPost Venture Capital judges found Elixir's business summary compelling because it expressed the critical need for advanced biofuel production and phytochemical co-products along with reduced carbon emissions and wastewater treatment that this project addresses.

Companies need to be in compliance, along with adequate financing to take advantage of alternative energy legislation," said Joe Rubin, Director, of FundingPost. "Elixir Bio-Tech Inc. has an exciting innovative rural algae biomass thrust and we know that FundingPost and the 'Pitching Across America' win will benefit them as they seek funding this year."

Press Release Contact: Gregory Edwards, Vice President, Elixir Bio-Tech Inc., Tel: 877-223-6316; Fax: 575-527-4252 or

SOURCE Elixir Bio-Tech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million
2. Bio-Tech Medical Software, Inc. Biometrics Joins Forces with the University of Central Florida to Fight Diversion and Help Combat Prescription Narcotic Drug Abuse
3. Elbit Imaging Evaluating Establishment of a Subsidiary to Hold its Bio-Tech and Medical Investments
4. Weikang Bio-Technology Reports Second Quarter 2010 Financial Results
5. Weikang Bio-Technology to Present at Rodman and Renshaws Annual Global Investment Conference on September 14th 2010
6. Weikang Bio-Technology Issues 2010 and 2011 Fiscal Year Guidance
7. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
8. Fujitsu PalmSecure and HT Systems PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft
9. NEXCORE Technology Selected to Manufacture New Endoscopic Cryotherapy Device
10. Netsmart Technologies Selected by City and County of San Francisco to Provide Integrated Behavioral Healthcare Software System
11. Douglas Oberhelman Elected to Lilly Board of Directors
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE ... has adopted a stockholder rights plan (Rights Plan) in ... operating loss carryforwards (NOLs) under Section 382 of the ... --> PharmAthene,s use of its NOLs could ... change" as defined in Section 382 of the Code. ...
(Date:11/25/2015)... 2 nouvelles études permettent d , ... les souches bactériennes retrouvées dans la plaque dentaire ... . Ces recherches  ouvrent une nouvelle voie ... de l,un des problèmes de santé les plus ... --> 2 nouvelles études permettent d , ...
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... and HOLLISTON, Mass. , ... Inc. (Nasdaq: HART ), a biotechnology company developing ... CEO Jim McGorry will present at the ... 1, 2015 at 2:30 p.m. PT. The presentation will ... for 30 days. Management will also be available at ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/19/2015)... , Nov. 19, 2015  Based on its ... & Sullivan recognizes BIO-key with the 2015 Global Frost ... year, Frost & Sullivan presents this award to the ... catering to the needs of the market it serves. ... line meets and expands on customer base demands, the ...
(Date:11/19/2015)... YORK , Nov. 19, 2015  Although some ... market is dominated by a few companies, according to ... companies own 51% of the market share of the ... The World Market for Molecular Diagnostic s ... "The market is still controlled by one company ...
Breaking Biology News(10 mins):